¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
ÀÏÀÚ
ÆÄÀÏ
Á¦¸ñ
±â°ü¸í
07-16
[¸Þ¸®Ã÷Áõ±Ç/À±¿©»ï] Policy Watcher :Çѱ¹ ±ÝÅëÀ§(7¿ù): ÀλóÀº..
¸Þ¸®Ã÷Áõ±Ç
07-16
[Naver (035420)] Long-term growth thesis intact
»ï¼ºÁõ±Ç
07-16
[Daewoong Pharmaceutical (069620)] 2Q results to beat on to ..
»ï¼ºÁõ±Ç
07-16
[Kakao (035720)] Challenges to growth strategy
»ï¼ºÁõ±Ç
07-16
[APR (278470)] 2Q results to make new highs
»ï¼ºÁõ±Ç
07-16
[µðÁöÅÐ ÀÚ»ê] ¿ÂüÀÎ ½ÃÀåÀ» ³Ñ¾î ±ÝÀ¶½ÃÀå±îÁö ³Ñº¸´Â Hyperli..
»ï¼ºÁõ±Ç
07-16
[7¿ù 4ÁÖ] Ķ¹Ú - ÁÖ°£ ¸ÅÅ©·Î/Å׸¶ ͏°´õ
»ï¼ºÁõ±Ç
07-16
[HYPERLIQUID STRATEGIES INC (NAS:PURR)] HyperliquidÀÇ HYPE Åä..
»ï¼ºÁõ±Ç
07-16
[ÇÏÀÌÆä¸®¾ð µðÆÄÀÌ (NAS:HYPD)] HyperliquidÀÇ HYPE ÅäÅ«, º¸À¯..
»ï¼ºÁõ±Ç
07-16
[Åë½Å¼ºñ½º] AI ÀÎÇÁ¶ó¿¡¼ »õ·Î¿î ÁÂÇ¥¸¦ ã´Ù
»ï¼ºÁõ±Ç
07-16
Áß±¹ 2Q ¹× 6¿ù ÁÖ¿ä °æÁ¦ ÁöÇ¥: ´ç»ç ¿¹»ó ºÎÇÕ; ³»¼ö ºÎÁø ¼Ó ..
»ï¼ºÁõ±Ç
07-16
[LGÀ¯Ç÷¯½º (032640)] ¼ºÀå°ú ȯ¿øÀÌ ÇÔ²²ÇÏ´Â ±¸°£
»ï¼ºÁõ±Ç
07-16
[ÇѶóij½ºÆ® (125490)] Co-day Take-away: ÇϹݱ⿡ ·Îº¿ ¸ÅÃâ ½Ã..
»ï¼ºÁõ±Ç
07-16
[ETFact Check] ÁÙ¿©¼ ´õ ¾µ¸ð ÀÖ´Â, ¾ÐÃàÇü ETF
»ï¼ºÁõ±Ç
07-16
[SNT¸ðƼºê (064960)] Co-day Take-aways: ¼û¾î ÀÖ´ø °¡Ä¡, ¹Ýµµ..
»ï¼ºÁõ±Ç
Àüü : 342
óÀ½
ÀÌÀü
[1]
[2]
[3]
[4]
[5]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
ÃֱٰԽù°